1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Refractory Solid Tumors: new trials by email Literature Review of Refractory Solid Tumors trials Research Report on Refractory Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors PEEL-224, Vincristine, Temozolomide (TMZ) - Refractory Solid Tumors, Relapsed Solid Tumors | Phase 1 / Phase 2 | Recruiting | Theodore Laetsch | 59 | 2025-03-23 | 2026-10-06 |
| Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation Arsenic trioxide - Refractory Solid Tumors | Phase 2 | Unknown | Ruijin Hospital | 20 | 2021-04-20 | 2021-05-13 |
| A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC) KB-0742 - Relapsed Solid Tumors, Refractory Solid Tumors | Phase 1 / Phase 2 | Terminated | Kronos Bio | 135 | 2021-02-08 | 2025-02-17 |
| A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors Hydralazine and magnesium valproate - Refractory Solid Tumors | Phase 2 | Completed | National Institute of Cancerología | 15 | 2005-09-01 | 2006-11-28 |
Lymphoma, Non-Hodgkin (1) · Neuroblastoma (1) · Recurrence (1) · Rhabdomyosarcoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Myosarcoma (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1)
Arsenic Trioxide (1) · Hydralazine (1) · Temozolomide (1) · Valproic Acid (1) · Vincristine (1)
Kronos Bio (1) · National Institute of Cancerología (1) · Ruijin Hospital (1) · Theodore Laetsch (1)
United States (2) · China (1) · Mexico (1) · Spain (1) · United Kingdom (1)
Alfonso Duenas-Gonzalez, MD PhD (1) · Jacquelyn Crane, MD (1) · Jun Zhang, MD & PhD (1) · Min Lu, Ph. D (1)
2023 (1)